<?xml version="1.0" encoding="UTF-8"?><?xml-stylesheet type="text/xsl" href="static/style.xsl"?><OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd"><responseDate>2026-04-04T05:50:37Z</responseDate><request verb="GetRecord" identifier="oai:www.recercat.cat:2445/104525" metadataPrefix="oai_dc">https://recercat.cat/oai/request</request><GetRecord><record><header><identifier>oai:recercat.cat:2445/104525</identifier><datestamp>2025-12-04T21:12:56Z</datestamp><setSpec>com_2072_1057</setSpec><setSpec>col_2072_478781</setSpec><setSpec>col_2072_478917</setSpec></header><metadata><oai_dc:dc xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:doc="http://www.lyncode.com/xoai" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
   <dc:title>Reduced adenosine uptake and its contribution to signaling that mediates profibrotic activation in renal tubular epithelial cells: implication in diabetic nephropathy.</dc:title>
   <dc:creator>Kretschmar, Catalina</dc:creator>
   <dc:creator>Oyarzún, Carlos</dc:creator>
   <dc:creator>Villablanca, Cristopher</dc:creator>
   <dc:creator>Jaramillo, Catherinne</dc:creator>
   <dc:creator>Alarcón, Sebastián</dc:creator>
   <dc:creator>Perez, Gustavo</dc:creator>
   <dc:creator>Díaz-Encarnación, Montserrat M. M.</dc:creator>
   <dc:creator>Pastor Anglada, Marçal</dc:creator>
   <dc:creator>Garrido, Wallys</dc:creator>
   <dc:creator>Quezada, Claudia</dc:creator>
   <dc:creator>San Martín, Rody</dc:creator>
   <dc:subject>Diabetis</dc:subject>
   <dc:subject>Cèl·lules epitelials</dc:subject>
   <dc:subject>Adenosina</dc:subject>
   <dc:subject>Diabetes</dc:subject>
   <dc:subject>Epithelial cells</dc:subject>
   <dc:subject>Adenosine</dc:subject>
   <dc:description>Altered nucleoside levels may be linked to pathogenic signaling through adenosine recep- tors. We hypothesized that adenosine dysregulation contributes to fibrosis in diabetic kid- ney disease. Our findings indicate that high glucose levels and experimental diabetes decreased uptake activity through the equilibrative nucleoside transporter 1 (ENT1) in proxi- mal tubule cells. In addition, a correlation between increased plasma content of adenosine and a marker of renal fibrosis in diabetic rats was evidenced. At the cellular level, exposure of HK2 cells to high glucose, TGF- β and the general adenosine receptor agonist NECA, induced the expression of profibrotic cell activation markers α -SMA and fibronectin. These effects can be avoided by using a selective antagonist of the adenosine A 3 receptor subtype in vitro. Furthermore, induction of fibrosis marker α -SMA was prevented by the A 3 receptor antagonist in diabetic rat kidneys. In conclusion, we evidenced the contribution of purinergic signaling to renal fibrosis in experimental diabetic nephropathy.</dc:description>
   <dc:date>2016-12-07T13:11:58Z</dc:date>
   <dc:date>2016-12-07T13:11:58Z</dc:date>
   <dc:date>2016-01-25</dc:date>
   <dc:date>2016-12-07T13:12:03Z</dc:date>
   <dc:type>info:eu-repo/semantics/article</dc:type>
   <dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
   <dc:identifier>1932-6203</dc:identifier>
   <dc:identifier>https://hdl.handle.net/2445/104525</dc:identifier>
   <dc:identifier>663309</dc:identifier>
   <dc:identifier>26808537</dc:identifier>
   <dc:language>eng</dc:language>
   <dc:relation>Reproducció del document publicat a: https://doi.org/10.1371/journal.pone.0147430</dc:relation>
   <dc:relation>PLoS One, 2016, vol. 11, num. 1, p. e0147430</dc:relation>
   <dc:relation>https://doi.org/10.1371/journal.pone.0147430</dc:relation>
   <dc:rights>cc-by (c) Kretschmar, Catalina et al., 2016</dc:rights>
   <dc:rights>http://creativecommons.org/licenses/by/3.0/es</dc:rights>
   <dc:rights>info:eu-repo/semantics/openAccess</dc:rights>
   <dc:format>20 p.</dc:format>
   <dc:format>application/pdf</dc:format>
   <dc:publisher>Public Library of Science (PLoS)</dc:publisher>
   <dc:source>Articles publicats en revistes (Bioquímica i Biomedicina Molecular)</dc:source>
</oai_dc:dc></metadata></record></GetRecord></OAI-PMH>